United States · FDA National Drug Code directory
Nicotine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59726-650_2051ed81-c87e-48b5-ac2f-68383ec23af9
- Product NDC
- 59726-650
- Form
- LOZENGE
- Composition / generic term
- nicotine polacrilex
- Labeler
- P & L Development, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250601
- Source listing expiry
- 20271231
Source-listed ingredients
- NICOTINE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 5 BOTTLE, PLASTIC in 1 BOX (59726-650-02) / 27 LOZENGE in 1 BOTTLE, PLASTIC · 59726-650-02
- 1 BOTTLE, PLASTIC in 1 BOX (59726-650-27) / 27 LOZENGE in 1 BOTTLE, PLASTIC · 59726-650-27
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →